News – Page 115 – Endpoints News

Novo Nordisk doubles US Wegovy prescriptions as shortages start to ease, but earnings fall below expectations

9 months ago

Exelixis’ Cabometyx misses survival endpoint, but will still file in prostate cancer

9 months ago

Updated: Novo Nordisk yanks Wegovy filing for heart failure from FDA, will resubmit next year

9 months ago

Weak China demand weighs on Illumina's sales

9 months ago

Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering

9 months ago

Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios

9 months ago

Updated: Amgen's Horizon buyout powers growth, with MariTide plans intact

9 months ago

CDC chief says new RSV guidance was meant to be ‘clear’ and ‘actionable’

9 months ago

Novo Nordisk goes after more compounders, expanding GLP-1 lawsuit campaign

9 months ago

TPG reveals $580M life sciences fund, which has already backed multiple biotechs

9 months ago

GSK wins second Zantac cancer case to go to trial

9 months ago

Bicycle Therapeutics focuses pipeline and streamlines leadership team

9 months ago

Eisai picks SEED Therapeutics for molecular glue deal worth as much as $1.5B

9 months ago

BioCryst culls Factor D inhibitor; Elevation Oncology’s stock plummets

9 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

9 months ago

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

9 months ago

Hims takes steps to lock up drug supply for its booming weight loss business

9 months ago

Genentech partners with cash-strapped Sangamo on epigenetic Alzheimer’s therapy

9 months ago

Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder

9 months ago

Japanese government grants Shinobi $59M for cell therapy development

9 months ago

Merck enlists partner Daiichi Sankyo to develop T cell engager from Harpoon acquisition

9 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

9 months ago

Bayer details 3,200 job cuts so far, spotlights ‘momentum’ in pharma pipeline

9 months ago

Ultimovacs’ cancer vaccine flunks again — this time in head and neck cancer

9 months ago

First page Previous page 112 113 114115116 117 118 Next page Last page